Results 111 to 120 of about 1,664 (165)

Long-Acting Growth Hormone for Pediatric Growth Hormone Deficiency. [PDF]

J Endocr Soc
Albers N, Cadarette S, Feakins B, Arregui M, Ebohon S, Lai P, Raveendran S, Kjelgaard-Hansen M, Andersen C, Zhao C, Smith A, Geffner M.   +11 more
europepmc   +1 more source

Systemic pathways linking subcutaneous therapies to gastrointestinal adverse effects: A Narrative review of mechanisms and mitigation strategies. [PDF]

Indian J Pharmacol
Singh A, Yadav D, Singh MP.
europepmc   +1 more source

Commentary on "Somatrogon in pediatric growth hormone deficiency: a comprehensive review of clinical trials and real-world considerations". [PDF]

Ann Pediatr Endocrinol Metab
Kim YM.
europepmc   +1 more source

Distinct Glucose Profiles with Daily and Weekly Growth Hormone Therapy Revealed by Continuous Glucose Monitoring. [PDF]

J Endocr Soc
Taguchi T, Kimura K, Tsuji S, Ito S, Takamura S, Shimotatara H, Shimizu N, Kubo H, Hoshiyama A, Hayashi A, Takano K, Miyatsuka T.   +11 more
europepmc   +1 more source

Diabetic ketoacidosis induced by long-acting growth hormone in a child without preexisting diabetes. [PDF]

JCEM Case Rep
Mustafa M, Hannon TS, Fuqua JS.
europepmc   +1 more source

Long-acting growth hormones: innovations in treatment and guidance on patient selection in pediatric growth hormone deficiency. [PDF]

Ann Pediatr Endocrinol Metab
Rodaro C, Tamaro G, Faleschini E, Tornese G.   +3 more
europepmc   +1 more source

Recombinant Human GH in Managing Refractory Hypoglycemia in a Young Patient With Embryonal Rhabdomyosarcoma. [PDF]

JCEM Case Rep
Belamkar AV, Shah VN, Patadia P, Abfall A, Priscu A.   +4 more
europepmc   +1 more source

Gender differences in drug-induced precocious puberty: a real-world analysis of adverse event reports from the FDA FAERS database (2004-2024). [PDF]

BMC Pediatr
Song B, Zhang P, Chen S, Zhang Y, Hu J.
europepmc   +1 more source